Home From critical care nephrology to critical care blood purification
Article Open Access

From critical care nephrology to critical care blood purification

  • Rongli Yang , Xiukai Chen , Suwei Li , Xiaoting Wang and Dawei Liu EMAIL logo
Published/Copyright: March 31, 2021

Introduction

Since Claudio Ronco and Rinaldo Bellomo proposed Critical Care Nephrology (CCN) more than 20 years ago,[1] international CCN organizations such as Acute Dialysis Quality Initiative (ADQI) and Acute Kidney Injury Network (AKIN) have been established successively. The definition and staging of acute kidney injury (AKI) were unified,[2, 3, 4] a large number of academic studies related to AKI were completed, and a series of guidelines or consensus on AKI and Continuous Renal Replacement Therapy (CRRT) were published.[4, 5, 6, 7, 8] The vigorous development of CCN has enabled patients with severe AKI to get standardized treatment, and at the same time, CRRT has been well promoted in intensive care units (ICUs). However, blood purification in the ICU is not limited to Renal Replacement Therapy (RRT); there are many extrarenal indications for CRRT, and severely ill patients may also need other blood purification techniques such as apheresis or adsorption. Hiromichi Suzuki and Hiroyuki Hirasawa of Japan described blood purification in ICU in their book Acute Blood Purification published in 2010.[9] Claudio Ronco and others have successively proposed the concepts of Multiple Organ Support Therapy (MOST) and Extracorporeal Organ Support (ECOS), both of which use extracorporeal blood purification technology to provide multiple organ support treatment for critically ill patients with Multiple Organ Dysfunction Syndrome (MODS).[10, 11] With the rapid development of critical care medicine in China, the application of blood purification in ICUs is also increasing. In order to differ from traditional blood purification, we collectively refer to all blood purification treatments implemented in the ICU for critically ill patients as Critical Care Blood Purification (CCBP). After years of theoretical development and clinical practice, CCBP has developed not only as a technology, but as a scientific system with distinctive features in basic theories, clinical application principles and methods, and treatment implementation rules. We have systematically explained CCBP.[12, 13] We gave a scientific definition of CCBP and summarized the four major characteristics of CCBP that are different from traditional blood purification.

The definition and research contents of critical care blood purification

CCBP is not just a set of technologies, but an interdisciplinary subject of critical care medicine and blood purification. CCBP is a science that studies the correlation and changes laws between the body’s internal environment and critical illnesses and studies as well as uses blood purification technologies to treat critical illnesses under the guidance of critical medicine theory.[12]CCBP not only needs to research and apply various blood purification techniques, but also needs to conduct in-depth research on the internal environment disorders caused by various severe diseases under the guidance of critical care medicine theory. Of course, the development of CCBP is inseparable from the support of technology. CCBP treatment often requires a variety of blood purification techniques or technique combinations, and these technologies are also the research objects of CCBP. CCBP techniques mainly include hemofiltration, hemodialysis, plasmapheresis, adsorption technologies, extracorporeal membrane oxygenation (ECMO), extracorporeal carbon dioxide removal (ECCO2R), and some combination techniques. CCBP is gradually breaking through the traditional “organ” and “replacement” levels, paying more attention to the internal environment and its regulation technology, and has its own characteristics and mode of action.

As a new science, CCBP itself is constantly developing, and its research content will continue to deepen and enrich. In an ICU, those who need blood purification treatment include not only patients with AKI, but also critically ill patients with other organs or systems involved. From the perspective of research scope, CCN is a major branch of CCBP. In addition to the kidneys, CCBP can also cover multiple organs or systems such as the liver, pancreas, heart, lung, immune system, nervous system, and muscles. At present, the research on blood purification treatment in these fields is not as in-depth as the research on renal supportive treatment. There is little unified standard and norm for blood purification treatment in these critically ill patients. If the successful experience of CCN is copied to other CCBP subspecialties, it will improve the prognosis of severely ill patients with other organ failures.

The main characteristics of critical care blood purification

As an emerging interdisciplinary subject, CCBP has distinct characteristics, mainly in the following aspects:

Critical care blood purification is inseparable from the guidance of critical care medicine theory

Critical care medicine has developed rapidly in recent years, enabling more and more critically ill patients to receive effective treatment. One of the main reasons that critical care medicine can improve the prognosis of patients is to emphasize the early detection and early intervention of severe diseases, as well as the concept of organ protection, such as early detection and treatment of shock, and lung protection strategies for acute respiratory distress syndrome. In addition, critical care medicine attaches importance to the study of the interaction between organs, such as cardiorenal syndrome, hepatorenal syndrome, and multiple organ dysfunction syndrome. Paying attention to the interaction between organs helps to balance a variety of treatment contradictions in the treatment process, thereby promoting the recovery of organ function and improving the prognosis. This treatment concept has also had a huge impact on CCBP. Taking acute renal failure and renal replacement therapy as examples, in order to achieve early detection and intervention of acute renal failure, the concept of “acute kidney injury” came into being;[2] in order to protect the damaged kidney, the traditional approach of “renal replacement therapy” is gradually replaced by the concepts of “renal support therapy” and “multiple organ support therapy”.[14] Therefore, although the renal support treatment in CCBP is similar to the traditional RRT, there are obvious differences in the treatment indications and timing, as well as the method and dosage.

In addition, the volume adjustment range of critically ill patients is narrowed, and both insufficient volume and fluid overload will affect the prognosis.[15] The progress of critical care medicine in the field of hemodynamics and fluid therapy also has a great impact on the volume management of CCBP. For example, when CRRT is performed on patients with unstable hemodynamics, only goal-directed treatment under the guidance of hemodynamics can achieve accurate and appropriate volume management, thereby improving the prognosis of those patients and their kidneys.[7]

Personnel engaged in critical care blood purification must master the theories and skills of critical care medicine

The fact that CCBP is inseparable from the guidance of critical care medicine theory also determines that the doctors who implement CCBP should have deep critical care medicine theory and skills, especially solid hemodynamic skills, in order to ensure the quality of CCBP. Whether CCBP is led by intensivists or nephrologists depends on the country or hospital. Which of the two forms is better or worse is still controversial.[16, 17, 18, 19] Vincent’s research shows that under the premise of good multidisciplinary consultation, closed ICU formats with intensivist-led care can improve the prognosis of patients with acute renal failure.[16] It shows that CCBP led by intensivists is a main direction for future development. Intensivists should strengthen their own learning and training and master the theory and skills of CCBP. Even for CCBP led by nephrologists, it should be ensured that they are trained in the theories and skills of critical care medicine.

Critical care blood purification takes the internal environment of critically ill patients as the main research object and intervention target

Various internal environmental disorders can occur to critically ill patients. In addition to the volume, electrolyte and acid–base imbalance frequently seen in AKI, severe internal environmental disorders can also be caused by hepatotoxins in liver failure, pathogenic microorganisms, and cytokine storms in severe infections, pathogenic antibodies from autoimmune disease, exogenous drugs or poisons entering the body, hyperthermia caused by heat stroke, and so on.[20, 21]

Using blood purification technology to rebuild homeostasis to maintain a good internal environment for organs and cells throughout the body will help restore organ function and improve prognosis. Traditional blood purification pays attention to the replacement of organ functions, while CCBP pays more attention to the correction of internal environmental disorders caused by various reasons such as organ dysfunction. Taking the internal environment disorder of critically ill patients as the target of CCBP intervention rather than just organ function is helpful to focus on the whole body and correctly determine the intervention timing, method, and dose of CCBP, reflecting the advantages of CCBP’s systemic support.[5]

Critical care blood purification has the characteristics of integration

Due to the complexity and variability of critically ill patients, their internal environmental disorders are also diverse. Therefore, doctors are required to select appropriate blood purification techniques for patients and formulate individualized blood purification programs. Different from the relatively fixed treatment plan of traditional blood purification, CCBP often needs to flexibly select different blood purification techniques according to the changes of the patient’s condition, showing the characteristic of integration. We divide the integration of CCBP into synchronous integration and sequential integration. Synchronous integration refers to the use of Integrated Blood Purification Technique (IBPT, that is, different blood purification principles or methods are integrated in the one composite technique) to treat critically ill patients, such as the use of Molecular Adsorption Recirculation System (MARS) to treat liver failure. Sequential integration refers to the use of different blood purification techniques one after another to treat the same critically ill patient. For example, patients with hepatorenal syndrome are treated with plasma exchange first, followed by CRRT.

In summary, CCBP, as a discipline that intersects with critical care medicine, cannot be developed without the guidance of critical care medicine theory. CCBP takes the internal environment of critically ill patients as the research object and intervention target. Due to the complexity and variability of critically ill patients, it is determined that the way of CCBP is not fixed, and different blood purification techniques need to be flexibly selected, showing a characteristic of integration. At present, the international CCN has made great achievements. With the deepening of CCBP’s other subspecialty research and multidisciplinary cooperation, its concepts and technologies will inevitably be mastered by more clinical medical staff. The extensive and standardized application of CCBP will become another advantageous weapon that can significantly improve the prognosis of critically ill patients after mechanical ventilation.


Prof. Dawei Liu, Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China

Funding statement: None declared.

  1. Competing Interests

    Authors state no conflict of interest.

References

1 Ronco C, Bellomo R. Critical care nephrology: the time has come. Nephrol Dial Transplant 1998; 13: 264-7.10.1093/oxfordjournals.ndt.a027816Search in Google Scholar PubMed

2 Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12.Search in Google Scholar

3 Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.10.1186/cc5713Search in Google Scholar PubMed PubMed Central

4 Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013; 17: 204.10.1186/cc11454Search in Google Scholar PubMed PubMed Central

5 Ostermann M, Joannidis M, Pani A, Floris M, De Rosa S, Kellum JA, et al. Patient Selection and Timing of Continuous Renal Replacement Therapy. Blood Purif 2016; 42: 224-37.10.1159/000448506Search in Google Scholar PubMed

6 Bagshaw SM, Chakravarthi MR, Ricci Z, Tolwani A, Neri M, De Rosa S, et al. Precision Continuous Renal Replacement Therapy and Solute Control. Blood Purif 2016; 42: 238-47.10.1159/000448507Search in Google Scholar PubMed

7 Murugan R, Hoste E, Mehta RL, Samoni S, Ding X, Rosner MH, et al. Precision Fluid Management in Continuous Renal Replacement Therapy. Blood Purif 2016; 42: 266-78.10.1159/000448528Search in Google Scholar PubMed

8 Cerdá J, Baldwin I, Honore PM, Villa G, Kellum JA, Ronco C, et al. Role of Technology for the Management of AKI in Critically Ill Patients: From Adoptive Technology to Precision Continuous Renal Replacement Therapy. Blood Purif 2016; 42: 248-65.10.1159/000448527Search in Google Scholar PubMed

9 Kaizu K, Inada Y, Kawamura A, Oda S, Hirasawa H. Current status of blood purification in critical care in Japan. Contrib Nephrol 2010; 166: 4-10.10.1159/000314844Search in Google Scholar PubMed

10 Ronco C, Bellomo R. Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 2002; 25: 733-47.10.1177/039139880202500801Search in Google Scholar PubMed

11 Ronco C, Ricci Z, Husain-Syed F. From Multiple Organ Support Therapy to Extracorporeal Organ Support in Critically Ill Patients. Blood Purif 2019; 48: 99-105.10.1159/000490694Search in Google Scholar PubMed

12 Yang RL, Li SW, Chen XK. [Critical care blood purification: from technology to science]. Zhonghua Yi Xue Za Zhi 2017; 97: 2241-3.Search in Google Scholar

13 Liu DW, Yang RL, Chen XK. Critical care blood purification (in Chinese). first edition. Beijing: People’s Medical Publishing House 2017: 1-519.Search in Google Scholar

14 Husain-Syed F, Ricci Z, Brodie D, Vincent JL, Ranieri VM, Slutsky AS, et al. Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalk. Intensive Care Med 2018; 44: 1447-59.10.1007/s00134-018-5329-zSearch in Google Scholar PubMed

15 Ronco C, Kaushik M, Valle R, Aspromonte N, Peacock WF 4th. Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome: the “5B” approach. Semin Nephrol 2012; 32: 129-41.10.1016/j.semnephrol.2011.11.016Search in Google Scholar PubMed

16 Vincent JL. Critical care nephrology: a multidisciplinary approach. Contrib Nephrol 2007; 156: 24-31.10.1159/000102012Search in Google Scholar PubMed

17 Flaatten H, Darmon M. A nephrologist should be consulted in all cases of acute kidney injury in the ICU: yes. Intensive Care Med 2017; 43: 874-6.10.1007/s00134-017-4790-4Search in Google Scholar PubMed

18 Kellum JA, Hoste E. A nephrologist should be consulted in all cases of acute kidney injury in the ICU: No. Intensive Care Med 2017; 43: 877-9.10.1007/s00134-017-4712-5Search in Google Scholar PubMed

19 Morgan D. Optimal Role of the Nephrologist in the Intensive Care Unit: An Intensivist’s Opinion. Blood Purif 2017; 44: 267-8.10.1159/000478973Search in Google Scholar PubMed

20 Redant S, Hussein H, Mugisha A, Attou R, De Bels D, Honore PM, et al. Differentiating Hyperlactatemia Type A From Type B: How Does the Lactate/pyruvate Ratio Help. J Transl Int Med 2019; 7: 43-5.10.2478/jtim-2019-0010Search in Google Scholar PubMed PubMed Central

21 Babazadeh A, Mohseni Afshar Z, Javanian M, Mohammadnia-Afrouzi M, Karkhah A, Masrour-Roudsari J, et al. Influenza Vaccination and Guillain-Barré Syndrome: Reality or Fear. J Transl Int Med 2019; 7: 137-42.10.2478/jtim-2019-0028Search in Google Scholar PubMed PubMed Central

Published Online: 2021-03-31

© 2021 Rongli Yang, Xiukai Chen, Suwei Li, Xiaoting Wang, Dawei Liu, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.2478/jtim-2021-0015/html
Scroll to top button